The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, September 26, 2017
Medicago announced the start of a Phase 3 efficacy study for its seasonal quadrivalent influenza vaccine candidate.
read more
Wednesday, September 27, 2017
As an agency dedicated to promoting public health, and as fellow Americans, the staff at the FDA is doing all it can to support the immediate needs of...
read more
Wednesday, September 27, 2017
Thermo Fisher Scientific announced the launch of its new PureLink Fast Low-Endotoxin Plasmid Purification Midi and Maxi Kits.
read more
Wednesday, September 27, 2017
The FDA announced the names of the companies selected to participate in a first-of-its kind pilot program that will help revolutionize digital health ...
read more
Tuesday, October 03, 2017
Regen BioPharma scientists have used a standard biochemical assay to determine if some of its small molecules that have been shown to activate NR2F6 ...
read more
Thursday, October 05, 2017
In a recent clinical trial, a gene therapy to treat cerebral adrenoleukodystrophy effectively stabilized the disease's progression in 88 percent of ...
read more
Kadmon announced the FDA has granted orphan drug designation to KD025 for the treatment of chronic graft-versus-host disease.
read more
Cantargia AB announced that the United States Patent and Trademark Office has granted the company's patent application directed to the product ...
read more
The FDA awarded 15 new clinical trial research grants totaling more than $22 million to boost development of products for patients with rare diseases.
read more
Bristol-Myers Squibb has appointed Saurabh Saha, M.D., Ph.D. as senior vice president and global head of translational medicine in the company’s R&D ...
read more
Tuesday, October 10, 2017
The National Multiple Sclerosis Society has committed nearly $14 million to support 40 new MS research projects.
read more
Wednesday, October 11, 2017
Ansun BioPharma announced the FDA has granted Breakthrough Therapy Designation to experimental compound DAS181.
read more
SU2C has awarded 10 Catalyst clinical trial projects in which researchers from more than 30 institutions collaborate across academic and corporate ...
read more
Prometic Life Sciences announced the FDA has accepted its BLA for its plasminogen replacement therapy Ryplazim.
read more
BrainStorm announced that the first patients have been enrolled in the Phase 3 clinical trial of NurOwn for the treatment of ALS.
read more